The pandemic has highlighted what was already obvious before: shortages require pan-European action
The central focus will be the general conditions and framework needed to strengthen pharmaceutical production in Europe. National best practice models as well as individual experiences will be presented. Also, conflicts between access to and affordability of pharmaceutical supplies will be addressed.
A digital event as part of the associated programme of the German EU Council Presidency, organised by Pro Generika
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.